Baxter Return on Tangible Equity 2010-2025 | BAX
Current and historical return on tangible equity values for Baxter (BAX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Baxter Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2025-06-30 |
$-0.16B |
$-3.05B |
4.70% |
| 2025-03-31 |
$-0.56B |
$-3.37B |
15.82% |
| 2024-12-31 |
$-0.65B |
$-3.47B |
17.43% |
| 2024-09-30 |
$0.11B |
$-3.29B |
-2.95% |
| 2024-06-30 |
$2.48B |
$-4.03B |
-62.49% |
| 2024-03-31 |
$2.65B |
$-4.10B |
-55.56% |
| 2023-12-31 |
$2.66B |
$-3.24B |
-47.14% |
| 2023-09-30 |
$2.59B |
$-4.47B |
-38.91% |
| 2023-06-30 |
$-2.85B |
$-7.26B |
37.84% |
| 2023-03-31 |
$-2.46B |
$-7.57B |
31.64% |
| 2022-12-31 |
$-2.43B |
$-7.35B |
30.48% |
| 2022-09-30 |
$-2.38B |
$-7.99B |
28.73% |
| 2022-06-30 |
$1.01B |
$-8.20B |
-19.03% |
| 2022-03-31 |
$1.06B |
$-8.39B |
-44.14% |
| 2021-12-31 |
$1.28B |
$-8.51B |
230.52% |
| 2021-09-30 |
$1.21B |
$3.84B |
33.32% |
| 2021-06-30 |
$1.12B |
$3.48B |
30.77% |
| 2021-03-31 |
$1.07B |
$3.42B |
29.51% |
| 2020-12-31 |
$1.10B |
$3.84B |
31.33% |
| 2020-09-30 |
$0.91B |
$3.83B |
26.71% |
| 2020-06-30 |
$0.92B |
$3.39B |
27.96% |
| 2020-03-31 |
$0.99B |
$3.01B |
29.67% |
| 2019-12-31 |
$1.00B |
$3.41B |
29.34% |
| 2019-09-30 |
$1.32B |
$3.41B |
38.57% |
| 2019-06-30 |
$1.47B |
$3.53B |
39.13% |
| 2019-03-31 |
$1.50B |
$3.30B |
37.61% |
| 2018-12-31 |
$1.55B |
$3.45B |
36.12% |
| 2018-09-30 |
$1.06B |
$4.73B |
23.24% |
| 2018-06-30 |
$0.80B |
$4.46B |
17.19% |
| 2018-03-31 |
$0.72B |
$4.48B |
14.82% |
| 2017-12-31 |
$0.60B |
$4.64B |
12.12% |
| 2017-09-30 |
$1.03B |
$4.97B |
20.82% |
| 2017-06-30 |
$0.91B |
$5.31B |
18.53% |
| 2017-03-31 |
$1.86B |
$4.95B |
39.24% |
| 2016-12-31 |
$4.97B |
$4.57B |
105.02% |
| 2016-09-30 |
$4.93B |
$4.81B |
102.83% |
| 2016-06-30 |
$4.80B |
$4.60B |
106.16% |
| 2016-03-31 |
$3.92B |
$4.93B |
100.30% |
| 2015-12-31 |
$0.97B |
$4.83B |
31.69% |
| 2015-09-30 |
$1.72B |
$3.72B |
62.42% |
| 2015-06-30 |
$2.18B |
$2.15B |
91.87% |
| 2015-03-31 |
$2.37B |
$1.53B |
99.92% |
| 2014-12-31 |
$2.50B |
$3.61B |
98.27% |
| 2014-09-30 |
$1.87B |
$2.23B |
87.57% |
| 2014-06-30 |
$1.95B |
$2.13B |
102.41% |
| 2014-03-31 |
$2.02B |
$2.20B |
87.34% |
| 2013-12-31 |
$2.01B |
$1.99B |
77.39% |
| 2013-09-30 |
$2.18B |
$1.28B |
72.22% |
| 2013-06-30 |
$2.22B |
$3.76B |
60.73% |
| 2013-03-31 |
$2.29B |
$3.36B |
64.92% |
| 2012-12-31 |
$2.33B |
$3.66B |
65.04% |
| 2012-09-30 |
$2.30B |
$3.83B |
64.07% |
| 2012-06-30 |
$2.29B |
$3.26B |
61.58% |
| 2012-03-31 |
$2.24B |
$3.56B |
56.12% |
| 2011-12-31 |
$2.22B |
$3.69B |
52.85% |
| 2011-09-30 |
$2.18B |
$4.36B |
50.13% |
| 2011-06-30 |
$2.13B |
$4.37B |
49.36% |
| 2011-03-31 |
$2.05B |
$4.41B |
49.57% |
| 2010-12-31 |
$1.42B |
$4.28B |
34.94% |
| 2010-09-30 |
$1.57B |
$4.22B |
36.79% |
| 2010-06-30 |
$1.57B |
$3.66B |
35.42% |
| 2010-03-31 |
$1.63B |
$4.10B |
34.92% |
| 2009-12-31 |
$2.21B |
$5.08B |
47.32% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$12.604B |
$10.636B |
|
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
|
